The GLP-1 Movement
GLP-1 drugs began being approved by the US Federal Drug Administration for use in Type 2 Diabetics in 2005.[3] Their impact has been tremendous. The newest data shows that 1 in 7 Americans has tried or is currently on a GLP-1.[6] This article aims to answer the following questions: What is a GLP-1? Who is […]